Skip to main content
All lobbying filings

ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC)

Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO) · Trade association

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 22, 2026

Official filing document

 Bills named in this filing 3
  • HR 1262
    Mikaela Naylon Give Kids a Chance Act
  • S 932
    Give Kids a Chance Act of 2025
  • S 2296
    National Defense Authorization Act for Fiscal Year 2026
 Lobbying activity 3
Medicare/Medicaid

Issues related to reimbursement under Medicare Part B and Part D; Most Favored Nation (MFN).

Health Issues

Issues related to drug pricing, generally; 340B Drug Pricing Program; pharmacy benefit managers; drug patents and patent reporting requirements; H.R. 1262/S. 932, Give Kids a Chance Act.

Defense

BIOSECURE Act/S. Amdt. 3236 to S. 2296, the National Defense Authorization Act for FY2026.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem